According to the invention it was unexpectedly found that budesonide can be used for the treatment of cholestatic liver diseases such as PBC PSC and AC. In particular budesonide is highly effective when administered together with ursodeoxycholic acid.

The invention relates to novel medicaments containing a combination of 5-aminosalicylic acid and a medicament selected from the group consisting of budesonide 6-methyl prednisolone and prednisolone. The novel medicaments are especially useful for treating inflammatory diseases of the intestinal tract and the secondary diseases and possible associated illnesses.

According to the invention it was unexpectedly found that budesonide can be used for the treatment of cholestatic liver diseases such as PBC PSC and AC. In particular budesonide is highly effective when administered together with ursodeoxycholic acid.

According to the invention it was unexpectedly found that budesonide can be used for the treatment of cholestatic liver diseases such as PBC PSC and AC. In particular budesonide is highly effective when administered together with ursodeoxycholic acid.

According to the invention it was unexpectedly found that budesonide can be used for the treatment of cholestatic liver diseases such as PBC PSC and AC. In particular budesonide is highly effective when administered together with ursodeoxycholic acid.